STRIVE Post-Market Registry Study

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Olympus Corporation of the Americas
Study ID
NCT04302272
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Spiration Valve System (SVS) — DEVICE
    Spiration Valves are one-way endobronchial valves indicated for adult patients with shortness of breath and hyperinflation associated with severe emphysema in regions of the lung that have evidence of low collateral ventilation. The Spiration Valve is loaded in the deployment catheter, then passed through the channel of a flexible bronchoscope and deployed at the intended target location. The SVS device is designed to relieve the symptoms of shortness of breath and hyperinflation associated with severe emphysema without surgery.

Study Details

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

Key Dates

Start date
Oct 9, 2021
Status verified
Apr 2026
Primary completion
Dec 31, 2026
Completion
Oct 31, 2029

Study Design

Enrollment
150 participants (estimated)

Primary Outcome Measure

Incidence of pre-specified thoracic adverse events of special interest (TAEsSI) through 12 months following the first implantation procedure [ Time Frame: 12 months ]

Central Contacts

Locations (14)

FacilityCityStateZIPSite coordinators
Dignity Health St. Joseph's Hospital and Medical CenterPhoenixArizona85013
Gabrielle Ambrose
602-406-8875
Abid Khokar, MD (PRINCIPAL_INVESTIGATOR)
El Camino, Taft Center for Clinical ResearchMountain ViewCalifornia94040
Winston Ku
650-962-4623
Ganesh Krishna, MD (PRINCIPAL_INVESTIGATOR)
Harpreet Singh, MD (SUB_INVESTIGATOR)
University of MiamiCoral GablesFlorida33146
Tiffany Salcito
Trishul Siddharthan, MD (PRINCIPAL_INVESTIGATOR)
Northwestern University, Division of Pulmonary and Critical Care MedicineChicagoIllinois60611
Adriana Martinez
312-926-6680
Momen Wahidi, MD (PRINCIPAL_INVESTIGATOR)
University of ChicagoChicagoIllinois60637
Vanita Patel
773-702-1012
Kyle Hogarth, MD (PRINCIPAL_INVESTIGATOR)
LSU Health ShreveportShreveportLouisiana71130
Teresa Leeth
318-675-7298
Robert Holladay, MD (PRINCIPAL_INVESTIGATOR)
Beth Israel DecaconessBostonMassachusetts02215
Adnan Majid, MD (PRINCIPAL_INVESTIGATOR)
Memorial Hospital at GulfportGulfportMississippi39501
Emily Hughes
228-867-4998
Krista Casey
228-575-1825
Bobby Tullos, MD (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27710
Jessica Shier
919-668-9139
Coral Giovacchini, MD (PRINCIPAL_INVESTIGATOR)
Penn State Milton S. Hershey Medical CenterHersheyPennsylvania17033
Karen Bright
717-531-0003
Michael Reed, MD (PRINCIPAL_INVESTIGATOR)
Temple UniversityPhiladelphiaPennsylvania19140
Helga Criner
215-707-1559
Gerard Criner, MD (PRINCIPAL_INVESTIGATOR)
AnMed HealthAndersonSouth Carolina29621
Melissa Frankum
864-512-8734
Abhijit Raval, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White Research InstituteDallasTexas75204
Melyssa Monge
817-709-1066
Kumar Abhishek, MD (PRINCIPAL_INVESTIGATOR)
Gary Schwartz, MD (SUB_INVESTIGATOR)
University of Texas SouthwesternDallasTexas75390
Khyati Vadera
214-645-8000
Muhanned Abu-Hijleh, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

By condition

Related Studies